Severe Eosinophilic Asthma: Key Decisions That Drive Effective Strategies with Targeted Therapies

Gain expert guidance on current best practice for the treatment of severe asthma including an Interactive Decision Support Tool and expert commentaries.

Share

Program Content

Activities

Managing Severe Asthma
Expert Advice on Managing Severe Asthma
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2020

Expires: August 04, 2021

Activities

Poorly Controlled Asthma
Steps I Take in Poorly Controlled Asthma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2020

Expires: August 23, 2021

Biologics in Type 2 Asthma
Biologic Therapeutics for Type 2 Asthma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2020

Expires: September 20, 2021

Faculty

cover img faculity

Michael E. Wechsler, MD, MMSc

Professor of Medicine
Director,
NJH Cohen Family Asthma Institute
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Hospital
Denver, Colorado

cover img faculity

Bradley E. Chipps, MDFAAP, FACAAI, FAAAAI, FCCP

President
Medical Director

Capital Allergy & Respiratory Disease Center
Sacramento, California

cover img faculity

Nicola Alexander Hanania, MD, MS

Associate Professor of Medicine
Department of Pulmonary and Critical Care Medicine
Baylor College of Medicine
Houston, Texas

cover img faculity

Linda Rogers, MD

Associate Professor of Medicine
Mount Sinai National Jewish Health Respiratory Institute
Icahn School of Medicine at Mount Sinai
Clinical Director, Adult Asthma Program
Division of Pulmonary, Critical Care, and Sleep Medicine
Department of Medicine
Mount Sinai Health System
New York, New York

cover img faculity

Eileen Wang, MD, MPH

Assistant Professor
Division of Allergy and Immunology
Department of Medicine
National Jewish Health
University of Colorado School of Medicine
Denver and Aurora, Colorado

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Novartis Pharmaceuticals Corporation

Sanofi Genzyme and Regeneron Pharmaceuticals